BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo
Pharmaceuticals · 02.02.2025 · 18 (2) · 201
DOI: 10.3390/ph18020201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 02.02.2025. Verfasst von Xin-Xin Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Science and Technology Planning Project of Guangdong Province.
Abstract (Originalsprache)
Background/Objectives: BuZhong YiQi Formula (BZYQF) can alleviate type 2 diabetes mellitus (T2DM). However, its efficacy in managing postprandial hyperglycemia in T2DM needs to be further confirmed, and its underlying mechanism and pharmacodynamic material basis have not been sufficiently investigated.
Methods
A T2DM rat model was induced to measure postprandial glycemic responses following glucose and starch ingestion. In vitro assays of enzymatic inhibition and the kinetic mode were performed to evaluate the inhibitory effect of BZYQF on α-amylase and α-glucosidase activities. The main constituent contents of BZYQF in a simulated digestion assay were measured to screen the active constituents in BZYQF against α-amylase and α-glucosidase activities via Pearson correlation and multiple linear regression analyses. Finally, the total flavonoids were purified from BZYQF to perform in vitro activity validation, and the flavonoid constituent activity was verified through molecular docking.
Results
In vivo assays showed that BZYQF significantly reduced the blood glucose values of CON rats but not T2DM rats after glucose ingestion, while BZYQF significantly reduced the blood glucose levels by 15 min after starch ingestion in CON and T2DM rats, with more significant decreases in blood glucose levels in T2DM rats. In vitro enzymatic assays showed that BZYQF could inhibit the activities of α-amylase and α-glucosidase in competitive and non-competitive modes and in an uncompetitive mode, respectively. Furthermore, BZYQF showed a stronger inhibitory effect on α-glucosidase activity than on α-amylase activity. Simulated digestion showed that simulated gastric fluid and intestinal fluid changed the main constituent contents of BZYQF and their inhibition rates against α-amylase and α-glucosidase activities, and similar results were rarely found in simulated salivary fluid. Pearson correlation and multiple linear regression analyses revealed that the total flavonoids were the active constituents in BZYQF inhibiting α-amylase and α-glycosidase activities. This result was verified by examining the total flavonoids purified from BZYQF. A total of 1909 compounds were identified in BZYQF using UPLC-MS/MS, among which flavones were the most abundant and consisted of 467 flavonoids. Molecular docking showed that flavonoids in BZYQF were bound to the active site of α-amylase, while they were bound to the inactive site of α-glucosidase. This result supported the results of the enzyme kinetic assay.
Conclusions
BZYQF significantly alleviated postprandial hyperglycemia in T2DM rats by inhibiting α-amylase and α-glycosidase activities, in which flavonoids in BZYQF were the active constituents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, 280 Waihuan Road East in Guangzhou Higher Education Mega Center, Guangzhou 510006, China.
ORCID-Profile: Ze-Min Yang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Science and Technology Planning Project of Guangdong Province
- College Student Innovation Training Program in China
Zitieren
APA
Zeng, X. X., Wang, L., Wang, M. Y., Hu, Z. R., Li, X. K., Fei, G. J., Ling, L., Fan, Y. T., & Yang, Z. M. (2025). BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo. Pharmaceuticals, 18(2), 201. https://doi.org/10.3390/ph18020201
Vancouver
Zeng XX, Wang L, Wang MY, Hu ZR, Li XK, Fei GJ, et al. BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo. Pharmaceuticals. 2025;18(2):201. doi:10.3390/ph18020201
BibTeX
@article{Zeng2025,
author = {Zeng, Xin-Xin and Wang, Liang and Wang, Ming-Yu and Hu, Zhen-Ran and Li, Xiang-Ke and Fei, Guo-Jun and Ling, Ling and Fan, Yu-Ting and Yang, Ze-Min},
title = {BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {2},
pages = {201},
doi = {10.3390/ph18020201}
}
EUVIMED